Remy Luthringer, CEO at Minerva Neurosciences, Inc. (NERV), sold 1,300 shares at $2.64 ($3K) on 2020-12-16, disclosed to the SEC on 2020-12-16.
Seasonal sale ($3k) by CEO — this insider has traded NERV in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NERV | SELL | 2018-12-18 | $19K | — | Filing → |
| NERV | SELL | 2017-12-15 | $13K | — | Filing → |
| NERV | SELL | 2017-02-07 | $378K | — | Filing → |